Harjee, Rahana
Devji, Jalila
Barrett-Chan, Ella Katelyn
Khinda, Jas
Bedaiwy, Mohamed A.
Article History
Received: 8 March 2024
Accepted: 28 April 2024
First Online: 18 May 2024
Declarations
:
: Ethics approval was provided by the UBC Research and Ethics Institutional Review Board (H19-02324). Participants were consented following the institutional protocols.
: We have received consent to publish these results from all relevant participants or organizations.
: Dr. Bedaiwy reports grants and personal fees from Abbvie Inc, grants and personal fees from Allergan Inc, personal fees from Heron Inc, grants from Ferring Inc, and grants from Canadian Institute of Health Research, outside the submitted work. The remainder of the authors declare that they have no competing interests.